Hangzhou Bailit Biopharmaceuticals Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 5

Hangzhou Bailit Biopharmaceuticals General Information

Description

Developer of biopharmaceutical products designed to advance treatments and improve patient health outcomes. The company offers innovative drug formulations, stringent quality control, scalable manufacturing processes, and compliance with regulatory standards, thereby enabling healthcare providers and pharmaceutical companies to access effective medications that support disease management and patient care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 462, 4th Floor, Building E
  • Number 688 Bin'an Road, Changhe Street, Binjiang District
  • Hangzhou, Zhejiang 900000
  • China
+86 151
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Room 462, 4th Floor, Building E
  • Number 688 Bin'an Road, Changhe Street, Binjiang District
  • Hangzhou, Zhejiang 900000
  • China
+86 151

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hangzhou Bailit Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 25-Sep-2025 Completed Generating Revenue
2. Early Stage VC 17-Feb-2025 Completed Generating Revenue
1. Seed Round 31-Oct-2023 Completed Startup
To view Hangzhou Bailit Biopharmaceuticals’s complete valuation and funding history, request access »

Hangzhou Bailit Biopharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Hi-Tech Financial Investment Group Venture Capital Minority
Hangzhou Qianhe Private Equity Fund Management Venture Capital Minority
Asieris Pharmaceuticals Corporation Minority
Hangzhou Tailong Venture Capital Partnership Growth/Expansion Minority
Hangzhou Tigermed Consulting Company Corporation Minority
To view Hangzhou Bailit Biopharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Hangzhou Bailit Biopharmaceuticals FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process